Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01554397 · ClinicalTrials.gov registry record · Phase 2
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
A Phase 2 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 101
- Enrollment target
NCT01554397 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 101 participants.
The verdict
NCT01554397, a Phase 2 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether patients with cervical cancer treated with PET-guided Bone Marrow Sparing IMRT have less side effects with equal cancer control compared to standard radiation techniques (IMRT). The hypothesis is that PET-guided Bone Marrow Sparing IMRT will reduce acute hematologic and gastrointestinal toxicity and increase chemotherapy tolerance for cervical cancer patients treated with concurrent cisplatin.
Interventions
- DRUG Cisplatin
- RADIATION IMRT
- RADIATION PET-guided Bone Marrow-Sparing Intensity Modulated Radiation Therapy (IMRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2011-10-13 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01554397
The ClinicalTrials.gov registry entry for NCT01554397 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT01554397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01554397 about?
NCT01554397 is a clinical study titled "Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer". The purpose of this study is to find out whether patients with cervical cancer treated with PET-guided Bone Marrow Sparing IMRT have less side effects with equal cancer control compared to standard radiation techniques (IMRT). The hypothesis is that PET-guided Bone Marrow Sparing IMRT will reduce ac...
What is the current status of trial NCT01554397?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 101 participants. The study started on 2011-10-13. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT01554397?
The interventions under investigation include: Cisplatin (DRUG), IMRT (RADIATION), PET-guided Bone Marrow-Sparing Intensity Modulated Radiation Therapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT01554397?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.